2026年11月6日，康宁杰瑞制药-B（股票代码：09966）公告称，当日于香港联交所场内回购312,000股普通股，占回购前公司已发行股份（不包括库藏股）总数约0.0323%。本次回购每股价格介乎每股6.22港元至6.38港元，总金额约197.21万港元。
回购完成后，公司已发行股份（不包括库藏股）减少至965,393,697股，库藏股增至8,988,000股，已发行股本总数仍为974,381,697股。公司于2026年6月12日通过购回授权，可回购股份总数为96,850,669股，截至本次回购完成后，已累计回购3,113,000股。
公司表示，本次回购符合香港联交所相关上市规则及其他适用法律法规的要求。公告由公司执行董事徐霆签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.